These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34223778)

  • 1. Study of confounding factors influence on lung cancer diagnostics effectiveness using gas chromatography-mass spectrometry analysis of exhaled breath.
    Gashimova E; Osipova A; Temerdashev A; Porkhanov V; Polyakov I; Perunov D; Dmitrieva E
    Biomark Med; 2021 Aug; 15(11):821-829. PubMed ID: 34223778
    [No Abstract]   [Full Text] [Related]  

  • 2. Noninvasive detection of lung cancer by analysis of exhaled breath.
    Bajtarevic A; Ager C; Pienz M; Klieber M; Schwarz K; Ligor M; Ligor T; Filipiak W; Denz H; Fiegl M; Hilbe W; Weiss W; Lukas P; Jamnig H; Hackl M; Haidenberger A; Buszewski B; Miekisch W; Schubert J; Amann A
    BMC Cancer; 2009 Sep; 9():348. PubMed ID: 19788722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an Exhaled Breath Monitoring System with Semiconductive Gas Sensors, a Gas Condenser Unit, and Gas Chromatograph Columns.
    Itoh T; Miwa T; Tsuruta A; Akamatsu T; Izu N; Shin W; Park J; Hida T; Eda T; Setoguchi Y
    Sensors (Basel); 2016 Nov; 16(11):. PubMed ID: 27834896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Smoking with Metabolic Volatile Organic Compounds in Exhaled Breath.
    Chen X; Wang F; Lin L; Dong H; Huang F; Ghulam Muhammad K; Chen L; Gorlova OY
    Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29068415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
    Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
    Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors that influence the volatile organic compound content in human breath.
    Blanchet L; Smolinska A; Baranska A; Tigchelaar E; Swertz M; Zhernakova A; Dallinga JW; Wijmenga C; van Schooten FJ
    J Breath Res; 2017 Feb; 11(1):016013. PubMed ID: 28140379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of volatile organic compounds in exhaled breath by gas chromatography-mass spectrometry combined with chemometric analysis.
    Dallinga JW; Smolinska A; van Schooten FJ
    Methods Mol Biol; 2014; 1198():251-63. PubMed ID: 25270934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.
    Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P
    J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between cancer tissue derived and exhaled volatile organic compound from colorectal cancer patients. Preliminary results.
    De Vietro N; Aresta A; Rotelli MT; Zambonin C; Lippolis C; Picciariello A; Altomare DF
    J Pharm Biomed Anal; 2020 Feb; 180():113055. PubMed ID: 31877489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Volatile organic compounds in exhaled breath are independent of systemic inflammatory syndrome caused by intravenous lipopolysaccharide infusion in humans: results from an experiment in healthy volunteers.
    Peters AL; Gerritsen MG; Brinkman P; Zwinderman KAH; Vlaar APJ; Bos LD
    J Breath Res; 2017 Apr; 11(2):026003. PubMed ID: 28397711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analyses of volatile organic compounds (VOCs) from patients, tumors and transformed cell lines for the validation of lung cancer-derived breath markers.
    Filipiak W; Filipiak A; Sponring A; Schmid T; Zelger B; Ager C; Klodzinska E; Denz H; Pizzini A; Lucciarini P; Jamnig H; Troppmair J; Amann A
    J Breath Res; 2014 Jun; 8(2):027111. PubMed ID: 24862102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD.
    Gaida A; Holz O; Nell C; Schuchardt S; Lavae-Mokhtari B; Kruse L; Boas U; Langejuergen J; Allers M; Zimmermann S; Vogelmeier C; Koczulla AR; Hohlfeld JM
    J Breath Res; 2016 Apr; 10(2):026006. PubMed ID: 27082437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodal chemometric approach for the analysis of human exhaled breath in lung cancer patients by TD-GC × GC-TOFMS.
    Pesesse R; Stefanuto PH; Schleich F; Louis R; Focant JF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 May; 1114-1115():146-153. PubMed ID: 30745111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis by Volatile Organic Compounds in Exhaled Breath from Lung Cancer Patients Using Support Vector Machine Algorithm.
    Sakumura Y; Koyama Y; Tokutake H; Hida T; Sato K; Itoh T; Akamatsu T; Shin W
    Sensors (Basel); 2017 Feb; 17(2):. PubMed ID: 28165388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volatile organic compounds in exhaled breath: a promising approach for accurate differentiation of lung adenocarcinoma and squamous cell carcinoma.
    Li X; Shi L; Long Y; Wang C; Qian C; Li W; Tian Y; Duan Y
    J Breath Res; 2024 Aug; 18(4):. PubMed ID: 39019071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dependence of exhaled breath composition on exogenous factors, smoking habits and exposure to air pollutants.
    Filipiak W; Ruzsanyi V; Mochalski P; Filipiak A; Bajtarevic A; Ager C; Denz H; Hilbe W; Jamnig H; Hackl M; Dzien A; Amann A
    J Breath Res; 2012 Sep; 6(3):036008. PubMed ID: 22932429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geographical variation in the exhaled volatile organic compounds.
    Amal H; Leja M; Broza YY; Tisch U; Funka K; Liepniece-Karele I; Skapars R; Xu ZQ; Liu H; Haick H
    J Breath Res; 2013 Dec; 7(4):047102. PubMed ID: 24184568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Volatolomics analysis of exhaled breath and gastric-endoluminal gas for distinguishing early upper gastrointestinal cancer from benign.
    Xiang C; Yang H; Zhao Z; Deng F; Lv Y; Yang Y; Duan Y; Li W; Hu B
    J Breath Res; 2023 May; 17(3):. PubMed ID: 37094569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry.
    Ligor M; Ligor T; Bajtarevic A; Ager C; Pienz M; Klieber M; Denz H; Fiegl M; Hilbe W; Weiss W; Lukas P; Jamnig H; Hackl M; Buszewski B; Miekisch W; Schubert J; Amann A
    Clin Chem Lab Med; 2009; 47(5):550-60. PubMed ID: 19397483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Targeted and Untargeted Approaches in Breath Analysis for the Discrimination of Lung Cancer from Benign Pulmonary Diseases and Healthy Persons.
    Koureas M; Kalompatsios D; Amoutzias GD; Hadjichristodoulou C; Gourgoulianis K; Tsakalof A
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33946997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.